AIMS: To compare the accuracy of two plaque delineation methods for coronary computed tomographic angiography (CTA) to identify lipid-core plaque (LCP) using histology as the reference standard. METHODS AND RESULTS: Five ex vivo hearts were analysed by CTA and histology. LCP was defined by histology as fibroatheroma with core diameter/circumference >200 μm/>60° and cap thickness <450 μm. In CTA, plaque was manually delineated either as the difference between the inner and outer vessel walls (Method A) or as a direct tracing of plaque (Method B). Low-attenuation plaque was defined as an area with <90 Hounsfield units. Of 446 co-registered cross-sections, 55 (12%) contained LCP. In CTA, low-attenuation plaque area was larger as assessed with Method A compared with Method B (difference: 120 ± 60%). Although low-attenuation plaque was associated with the presence of LCP, the delineation Method B yielded higher diagnostic accuracy than Method A [area under the curve (AUC): 0.831 vs. 0.780, respectively, P = 0.005]. After excluding 'normal' cross-sections by CTA (n = 117), AUC for detecting LCP became similar between both methods (0.767 vs. 0.729, P = 0.07, respectively). CONCLUSION: Low-attenuation plaque in CTA is a diagnostic tool for LCP but prone to error if plaque is defined as the area between the inner and outer vessel walls and normal cross-sections are included in the assessment.
AIMS: To compare the accuracy of two plaque delineation methods for coronary computed tomographic angiography (CTA) to identify lipid-core plaque (LCP) using histology as the reference standard. METHODS AND RESULTS: Five ex vivo hearts were analysed by CTA and histology. LCP was defined by histology as fibroatheroma with core diameter/circumference >200 μm/>60° and cap thickness <450 μm. In CTA, plaque was manually delineated either as the difference between the inner and outer vessel walls (Method A) or as a direct tracing of plaque (Method B). Low-attenuation plaque was defined as an area with <90 Hounsfield units. Of 446 co-registered cross-sections, 55 (12%) contained LCP. In CTA, low-attenuation plaque area was larger as assessed with Method A compared with Method B (difference: 120 ± 60%). Although low-attenuation plaque was associated with the presence of LCP, the delineation Method B yielded higher diagnostic accuracy than Method A [area under the curve (AUC): 0.831 vs. 0.780, respectively, P = 0.005]. After excluding 'normal' cross-sections by CTA (n = 117), AUC for detecting LCP became similar between both methods (0.767 vs. 0.729, P = 0.07, respectively). CONCLUSION: Low-attenuation plaque in CTA is a diagnostic tool for LCP but prone to error if plaque is defined as the area between the inner and outer vessel walls and normal cross-sections are included in the assessment.
Authors: Hyuk-Jae Chang; Fay Y Lin; Sang-Eun Lee; Daniele Andreini; Jeroen Bax; Filippo Cademartiri; Kavitha Chinnaiyan; Benjamin J W Chow; Edoardo Conte; Ricardo C Cury; Gudrun Feuchtner; Martin Hadamitzky; Yong-Jin Kim; Jonathon Leipsic; Erica Maffei; Hugo Marques; Fabian Plank; Gianluca Pontone; Gilbert L Raff; Alexander R van Rosendael; Todd C Villines; Harald G Weirich; Subhi J Al'Aref; Lohendran Baskaran; Iksung Cho; Ibrahim Danad; Donghee Han; Ran Heo; Ji Hyun Lee; Asim Rivzi; Wijnand J Stuijfzand; Heidi Gransar; Yao Lu; Ji Min Sung; Hyung-Bok Park; Daniel S Berman; Matthew J Budoff; Habib Samady; Leslee J Shaw; Peter H Stone; Renu Virmani; Jagat Narula; James K Min Journal: J Am Coll Cardiol Date: 2018-06-05 Impact factor: 24.094
Authors: Rine Nakanishi; Anas Alani; Suguru Matsumoto; Dong Li; Michael Fahmy; Jeby Abraham; Christopher Dailing; Alexander Broersen; Pieter H Kitslaar; Khurram Nasir; James K Min; Matthew J Budoff Journal: Tex Heart Inst J Date: 2018-04-07
Authors: Karen Rodriguez; Alan C Kwan; Shenghan Lai; João A C Lima; Davis Vigneault; Veit Sandfort; Puskar Pattanayak; Mark A Ahlman; Marissa Mallek; Christopher T Sibley; David A Bluemke Journal: Radiology Date: 2015-06-02 Impact factor: 11.105
Authors: Janet Lo; Michael T Lu; Ezinne J Ihenachor; Jeffrey Wei; Sara E Looby; Kathleen V Fitch; Jinhee Oh; Chloe O Zimmerman; Janice Hwang; Suhny Abbara; Jorge Plutzky; Gregory Robbins; Ahmed Tawakol; Udo Hoffmann; Steven K Grinspoon Journal: Lancet HIV Date: 2015-01-09 Impact factor: 12.767
Authors: Andreas A Giannopoulos; Yiannis S Chatzizisis; Pal Maurovich-Horvat; Antonios P Antoniadis; Udo Hoffmann; Michael L Steigner; Frank J Rybicki; Dimitrios Mitsouras Journal: Atherosclerosis Date: 2016-06-23 Impact factor: 5.162
Authors: Pál Maurovich-Horvat; Dávid L Tárnoki; Ádám D Tárnoki; Tamás Horváth; Ádám L Jermendy; Márton Kolossváry; Bálint Szilveszter; Viktor Voros; Attila Kovács; Andrea Á Molnár; Levente Littvay; Hildo J Lamb; Szilard Voros; György Jermendy; Béla Merkely Journal: Clin Cardiol Date: 2015-10-23 Impact factor: 2.882